|
Toxiferine
|
D03.132.098.833 |
|
|
Ventilator Weaning
|
E02.041.625.950 |
|
|
Respiration, Artificial
|
E02.041.625 |
|
|
Prostaglandins A, Synthetic
|
D011455 |
[Analogs or derivatives of prostaglandin A that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGA.
] |
|
Pleural Cavity
|
D035422 |
[Paired but separate cavity within the THORACIC CAVITY. It consists of the space between the parietal and visceral PLEURA and normally contains a capillary layer of serous fluid that lubricates the pleural surfaces.
] |
|
Prostaglandins B
|
D011456 |
[Physiologically active prostaglandins found in many tissues and organs. They are potent pressor substances and have many other physiological activities.
] |
|
Thoracic Cavity
|
D035423 |
[The region of the thorax that includes the PLEURAL CAVITY and MEDIASTINUM.
] |
|
Prostaglandins D
|
D011457 |
[Physiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation, and have potential antithrombotic effects.
] |
|
Prostaglandins E
|
D011458 |
[(11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities.
] |
|
Parotid Region
|
D035421 |
[The region of the face on either side, around the PAROTID GLAND.
] |
|
Prostaglandins E, Synthetic
|
D011459 |
[Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE.
] |
|
Schistosoma haematobium
|
B01.050.500.500.736.715.770.680.510 |
|
|
Cardiovascular System
|
A07 |
|
|
Androstenedione
|
D06.472.334.851.968.875 |
|
|
Cunninghamia
|
B01.650.940.800.575.912.625.750.250 |
|
|
Prostaglandin Endoperoxides, Synthetic
|
D011450 |
[Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds.
] |
|
Datasets as Topic
|
L01.313.500.750.300.188.400.500 |
|
|
Prostaglandin-Endoperoxide Synthases
|
D011451 |
[Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor.
] |
|
15-Oxoprostaglandin 13-Reductase
|
D011452 |
[(5Z)-(15S)-11 alpha-Hydroxy-9,15-dioxoprostanoate:NAD(P)+ delta(13)-oxidoreductase. An enzyme active in prostaglandin E and F catabolism. It catalyzes the reduction of the double bond at the 13-14 position of the 15-ketoprostaglandins and uses NADPH as cofactor. EC 1.3.1.48.
] |
|
Cerium
|
D01.268.558.362.249 |
|
